MVMario Del Vecchio

Mario Del Vecchio

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mario Del Vecchio has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Network governance forms in healthcare: empirical evidence from two Italian cancer networks

    by Anna Romiti, Mario Del Vecchio, Gino Sartor

    Background: This study focuses on the application of Provan and Kenis’ modes of network governance to the specific field of public healthcare networks, extending the framework to an analysis of systems in which networks are involved. Thus, the aim of this study is to analyze and compare the governance of two cancer networks in two Italian regions that underwent system reconfiguration processes due to reforms in the healthcare system.Methods: A qualitative study of two clinical networks in the Italian healthcare system was conducted. The sample for interviews included representatives of the regional administration (n = 4), network coordinators (n = 6), and general and clinical directors of health organizations involved in the two networks (n = 25). Data were collected using semi-structured interviews.Results: Our study shows that healthcare system reforms have a limited impact on network governance structures. In fact, strong inertial tendencies characterize networks, especially network administrative organization models (NAO). Networks tend to find their own balance with respect to the trade-offs analyzed using a mix of formal and informal ties. Our study confirms the general validity of Provan and Kenis’ framework and shows how other specific factors and contingencies may affect the possibility that cancer networks find positive equilibria between competing needs of inclusivity and efficiency, internal and external legitimacy, and stability and flexibility. It also shows how networks react to external changes.Conclusions: Our study shows the importance of considering three factors and contingencies that may affect network effectiveness: a) the importance of looking at network governance modes not in isolation, but in relationship to the governance of regional systems; b) the influence of a specific network’s governance structure on the network’s ability to respond to tensions and to achieve its goals; and c) the need to take into account the role of professionals in network governance.


  • Myth #1: The Healthcare System Is Failing

    by Umberto Veronesi, Maurizio Mauri, Mario Del Vecchio, Patrizio Armeni, Vincenza Esposito, Mario Pezzillo Iacono, Lorenzo Mercurio, Joseph Polimeni

    • 12 December 2012
      • Vol. 29  (6) , 721-7

    [Nephrology management models].

    by Mario Del Vecchio

    • 12 December 2012
      • Vol. 29  (6) , 746-57

    [Lessons learned from the research project ''Institutional formats and organizational models for the range of services in nephrology''].

    by Mario Del Vecchio, Rosanna Coppo, Valeria D Tozzi, Francesco Pizzarelli, Giuseppe Quintaliani, Gina Meneghel, Ugo Teatini, Giovanni G Battaglia, Marco Formica, Giuseppe Enia, et al.

    • 1 November 2008
      • Vol. 9, 5S-23S

    [Cardiac sudden death in Italy. Dimensions, perceptions, policies and economic/financial impact].

    by Mario Del Vecchio, Luigi Padeletti

    This study is based on the consideration that sudden cardiac death (SCD) incidence is increasing in today's society and, despite the efforts of clinicians, there is great lack of awareness and focus for its prevention on behalf of society and institutions. During 2006 a research project on SCD was initiated in Italy by the CUSAS (Centro Universitario di Studi in Amministrazione Sanitaria) and the Institute for Internal Medicine and Cardiology of the University of Florence with the intention to: estimate the dimension(s) of the SCD phenomenon in the general population; underline the economical consequences of SCD; identify the causes for the lack of interest in SCD; evaluate the degree of use of biomedical technologies for SCD prevention, and compare the actual scenario with the ideal one (driven by treatment guidelines implementation); the last part of the study analyzes economical sustainability of the implementation of the 2006 European Society of Cardiology new guidelines. We estimated an occurrence of SCD in young subjects (between 35 and 65 years of age) of roughly 9300 cases per year (approximately 17% of total): nearly one case of SCD in 5 afflicts young and still active individuals. Causes of the phenomenon vary greatly: in older subjects the pathology that most frequently causes SCD is ischemic heart disease, whereas in younger subjects it is more often related to heart failure. The most optimistic hypothesis is that each year SCD causes the loss of nearly 600 000 life years. We came up with a first estimate of the socio-economic impact due to life years lost each year to SCD, using net individual work salary for the basis of the calculation. Results are extremely variable (between 6.482 and 12.216 millions of euros each year). Considering that half of the events occur in patients in whom SCD can be accurately predicted, due to their high risk factor, it is possible to estimate the financial investment necessary to prevent SCD in at least these individuals. The DRG tariff is used as a proxy for the economic calculation of the procedure costs. An additional investment of 310 million euros would have been necessary, which represents only 0.33% of the national health budget for that same year. We strongly believe that preventing SCD is not only financially feasible but very beneficial from the societal perspective.